Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Eur J Cancer ; 35(8): 1258-63, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10615238

RESUMO

Arsenic trioxide (As2O3), used to treat human diseases for centuries in traditional Chinese medicine, has been identified as a very effective antileukaemic agent, but its effect on solid tumours which could be more suitable for clinical treatment with arsenic compounds is still unknown. In this study, we investigated the in vitro effect of As2O3 at concentrations of 0.01-1 microM against six human malignant cell lines, MGC-803, HIC, MCF-7, HeLa, BEL-7402 and A549 cells. As2O3 inhibited growth and induced apoptosis in these malignant cells at varying degrees, in a time dose-dependent manner. The most marked effects were seen in the gastric cancer cell line, MGC-803. In contrast, minimal growth inhibition and induction of apoptosis occurred in human embryonic pulmonary cells following treatment with As2O3 found at the same concentrations. Changes in intracellular Ca2+, following As2O3 treatment were measured by Ca2+ sensitive fluorescent probe Indo-1/AM in flow cytometric assays. The increase in intracellular Ca2+ correlated with the sensitivity of these cells to As2O3, possibly indicating that a critical intracellular Ca2+ signal transduction pathway could be involved in As2O3-mediated cell-death and its selectivity. The marked sensitivity of MGC-803 cells in vitro suggests that As2O3 may be a potential antigastric cancer agent.


Assuntos
Antineoplásicos/uso terapêutico , Apoptose , Arsenicais/uso terapêutico , Óxidos/uso terapêutico , Neoplasias Gástricas/tratamento farmacológico , Trióxido de Arsênio , Cálcio/metabolismo , Divisão Celular/efeitos dos fármacos , DNA de Neoplasias/efeitos dos fármacos , Ensaios de Seleção de Medicamentos Antitumorais , Citometria de Fluxo , Humanos , Neoplasias Gástricas/patologia , Células Tumorais Cultivadas/efeitos dos fármacos
2.
Free Radic Biol Med ; 20(6): 801-6, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8728027

RESUMO

Tanshinone II-A (TSII-A) isolated from the root of Salvia miltorrhiza Bunge, a traditional medicine in China, is a derivative of phenanthrenequinone, which is known to have antioxidant properties. In the present study, effects of TSII-A on DNA damage by lipid peroxidation were investigated using liver cells, labeled with [3H] arachidonic acid, in the presence of FeCl2-DTPA. The results show that the nuclear DNA isolated from treated cells had higher radioactivity compared to controls and the radioactivity increased with longer incubation times. Purified lipid-DNA adducts had a characteristic fluorescent spectra and showed a decrease of hyperchromicity and melting point. TSII-A could inhibit the association of peroxidation products with DNA in liver cells and prevent a decrease in cell viability and in the the activity of O6-methylguanine acceptor protein with increasing incubation time. Compared with other antioxidants, TSII-A had a higher inhibitory ratio, which was similar to vitamin E and butylated hydroxy-toluene (BHT), but markedly stronger than NaN3, mannatol, and superoxide dismutase (SOD). These data suggest that TSII-A represents a new and effective antioxidant that inhibits the association of lipid peroxidation products with DNA. Its protective effect may be through breaking the chain reactions of peroxidation by scavenging lipid free radicals, thereby decreasing their cytotoxicity.


Assuntos
Antioxidantes/farmacologia , Dano ao DNA/efeitos dos fármacos , Peroxidação de Lipídeos , Fígado/metabolismo , Fenantrenos/farmacologia , Abietanos , Animais , Hidroxitolueno Butilado/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Adutos de DNA/efeitos dos fármacos , Adutos de DNA/metabolismo , Medicamentos de Ervas Chinesas/química , Guanina/análogos & derivados , Guanina/metabolismo , Quelantes de Ferro/farmacologia , Masculino , Malondialdeído/metabolismo , Ácido Pentético/farmacologia , Extratos Vegetais , Ratos , Ratos Sprague-Dawley , Salvia miltiorrhiza , Superóxido Dismutase/metabolismo , Vitamina E/farmacologia
3.
Int J Radiat Biol ; 61(2): 213-9, 1992 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-1351909

RESUMO

Hypocrellin-A (HC-A) isolated from Hypocrellia bambusae Sacc., is a new and effective photosensitizer. Illumination of sarcoma 180 cells with visible light in the presence of HC-A leads to a decrease in cell viability and 3H-TdR incorporation, causes DNA strand breakage, and results in the selective destruction of guanine moieties in DNA. HC-A photosensitization causes an increase in the theta 260/theta 280 ratio in the circular dichroism spectra of DNA in vitro. Of the four usual 2'-deoxynucleotides illuminated in the presence of HC-A only 2'-deoxyguanylic acid was destroyed.


Assuntos
Dano ao DNA , Medicamentos de Ervas Chinesas/farmacologia , Perileno/análogos & derivados , Quinonas/farmacologia , Radiossensibilizantes/farmacologia , Animais , Divisão Celular/efeitos dos fármacos , DNA de Cadeia Simples/efeitos dos fármacos , Perileno/farmacologia , Fenol , Fotólise
4.
Artigo em Inglês | MEDLINE | ID: mdl-2147061

RESUMO

Hyperthermia (42-44 degrees C) and photosensitizing therapy can destroy S180 tumor cells, reduce malignant ascites and prolong the survival times of mice with carcinomas. The highest curative effect was observed when using a combination of the two treatments. Heating to 44 degrees C has a greater destructive effect on tumor cells than has heating to 42 degrees C. The results show that this is due to a synergistic interaction between these two treatments. The fluorescence spectrum of S180 cells was determined before and after treatment, and the indication was that the synergistic effect is probably related to a new fluorescence product; the greater the intensity of the new fluorescence, the more marked the synergy of hyperthermia and photosensitizing therapy. The maximum emission wavelength was 460nm (excitation wavelength 370nm).


Assuntos
Fotorradiação com Hematoporfirina , Hematoporfirinas/uso terapêutico , Hipertermia Induzida , Neoplasias Hepáticas Experimentais/terapia , Animais , Terapia Combinada , Feminino , Derivado da Hematoporfirina , Hematoporfirinas/farmacologia , Humanos , Hipertermia Induzida/métodos , Lasers , Leucemia P388/tratamento farmacológico , Leucemia P388/patologia , Neoplasias Hepáticas Experimentais/patologia , Masculino , Camundongos , Camundongos Endogâmicos DBA , Sarcoma 180/tratamento farmacológico , Sarcoma 180/patologia , Células Tumorais Cultivadas/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA